REVOLUTION Medicines Revenue and Competitors
Estimated Revenue & Valuation
- REVOLUTION Medicines's estimated annual revenue is currently $81.6M per year.
- REVOLUTION Medicines received $56.0M in venture funding in April 2018.
- REVOLUTION Medicines's estimated revenue per employee is $217,000
- REVOLUTION Medicines's total funding is $486.9M.
Employee Data
- REVOLUTION Medicines has 376 Employees.
- REVOLUTION Medicines grew their employee count by 28% last year.
REVOLUTION Medicines Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 150% | N/A | N/A |
#5 | $1.4M | 9 | 0% | N/A | N/A |
#6 | $11.5M | 74 | -12% | N/A | N/A |
#7 | $0.4M | 275 | 10% | $236.7M | N/A |
#8 | $4M | 51 | -74% | $160M | N/A |
#9 | $2.5M | 16 | 33% | N/A | N/A |
#10 | $3.3M | 21 | -12% | N/A | N/A |
What Is REVOLUTION Medicines?
REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. Our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. We pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.
keywords:Biotechnology,Healthcare,Pharmaceuticals$486.9M
Total Funding
376
Number of Employees
$81.6M
Revenue (est)
28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
REVOLUTION Medicines News
Revolution Medicines (NASDAQ:RVMD) Rating Increased to Hold at Zacks Investment Research. Posted by admin on Apr 16th, 2022.
Revolution Medicines : RMC-9805 (RM-036), a First-in-Class, Orally-Bioavailable, Tri-Complex Covalent KRAS-G12D(ON) Inhibitor, Drives Profound...
Wall Street is positive on Revolution Medicines Inc (RVMD). On average, analysts give RVMD a Strong Buy rating. The average price target is...
... highlighting challenges and opportunities of health care revolution ... its global leadership position at the forefront of medicines research and ...
In June, Frontier Medicines launched with a $67 million Series A ... And in July, Revolution Medicines raised a $100 million equity round for its ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34M | 382 | 4% | $17.5M |
#2 | $50M | 400 | N/A | N/A |
#3 | $67.5M | 409 | -1% | $204.5M |
#4 | $300M | 442 | 1% | N/A |
#5 | $83.4M | 469 | 0% | $61.1M |
REVOLUTION Medicines Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2015-02-05 | $45.0M | A | Third Rock Ventures, LLC | Article |
2016-12-21 | $25.0M | A | The Column Group | Article |
2018-04-25 | $56.0M | B | Nextech Invest | Article |
REVOLUTION Medicines Executives
Name | Title |
---|---|
Mark Goldsmith | President & CEO |
Mark Goldsmith | CEO and President |
Peg Horn | Chief Operating Officer |
Tammy Fischetti | Executive Assistant to the CEO |
Wally Reiher | VP Information Services |
XIAOLIN wang | SVP, Clinical Development |
Mark Goldsmith | President & CEO |
Jack Anders | VP, Finance & Principal, Accounting Officer |
Luan Wilfong | Senior Vice President Human Resources |
Elena Koltun | VP, Medicinal Chemistry |
Jason Lindow | Vice President, Clinical Operations |
Mark Goldsmith | CEO and President |
Shaoling Li | Sr. Vice President, CMC and Quality |
Tamara Kale | Vice President, Associate General Counsel, Intellectual Property |
Steve Kelsey | President |
Jan Smith | Senior Vice President, Head of Biology |
Jeff Cislini | SVP, General Counsel and Corporate Secretary |
Marieke Van | VP Program, Portfolio, and Alliance Management |
David Arrington | Senior Vice President Investor Relations & Corporate Affairs |
Xiaolin Wang | EVP Clinical Development |